4 Basebio Ag Na O.N Ret. on equity

What is the Ret. on equity of 4 Basebio Ag Na O.N?

The Ret. on equity of 4 Basebio Ag Na O.N. is -26.40%

What is the definition of Ret. on equity?



Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.

ttm (trailing twelve months)

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Ret. on equity of companies in the Health Care sector on XETRA compared to 4 Basebio Ag Na O.N

What does 4 Basebio Ag Na O.N do?

2invest AG, an investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally. The company was formerly known as 4basebio AG and changed its name to 2invest AG in January 2021. 2invest AG is based in Heidelberg, Germany.

Companies with ret. on equity similar to 4 Basebio Ag Na O.N